Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 20 Fast-growings companies in PCSK9 Inhibitors
by Most Patent Filing In 3 Years in the world in 2019

The PCSK9 Inhibitors top 20 is Discovery PatSnap’ annual ranking of the top 20 Most Patent Filing In 3 Years PCSK9 Inhibitors Fast-growings in the world. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2019, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
The PCSK9 inhibitors are a class of injectable drugs approved in 2015 that have been shown to dramatically lower LDL cholesterol levels -- by up to 60% in some cases -- when combined with a statin.. PCSK9 inhibitors are monoclonal antibodies (MABs), a type of biologic drug. They bind to and inactivate an enzyme in the liver called proprotein convertase subtilisin kexin 9 (PCSK9).
#
Company Name
Region
Tech Topics
Total
1
Patent: 32
2
Health care,Biopharmaceutical,TUMOR NECROSIS FACTOR BLOCKER,
...[+2]
Patent: 13
3
Switzerland
Medicine,Health care,Drug,
...[+2]
Patent: 11
4
Basel-Stadt, Switzerland
Dosage form,Health care,Medicine,
...[+2]
Patent: 11
5
Hovedstaden, Denmark
Insulin,Health care,Haemophilia,
...[+2]
Patent: 10
6
Patent: 5
7
Health care,Mitral valve surgery,Health equity,
...[+2]
Patent: 5
8
Patent: 4
9
Medicine,Health care,Drug class,
...[+2]
Patent: 3
10
IF, FR
Patent: 2
11
Patent: 2
12
Île-de-France, France
Patent: 2
13
Patent: 2
14
Patent: 2
15
Pokka Corp.
Aichi, Japan
Food industry,Soft drink,Fountain,
...[+1]
Patent: 1
16
Patent: 1
17
Health care,Biopharmaceutical,Drug,
...[+2]
Patent: 1
18
National security,BCG vaccine,HIV vaccine,
...[+2]
Patent: 1
19
Patent: 1
20
Patent: 1
Page generation time: May 17 2025